TY  - GEN
AU  - Pae, Sookhee
AU  - Sedukhina, Anna S
AU  - Sugiyama, Runa
AU  - Atanacio, Sarah J
AU  - Ohara, Tatsuru
AU  - Ishii, Masato
AU  - Minagawa, Kimino
AU  - Akichjev, Romaan
AU  - Go, Fumie
AU  - Chandankeri, Zayan
AU  - Janjetic, Zoran M M
AU  - Sato, Eri
AU  - Yamaura, Ayako
AU  - Meguro, Rei
AU  - Palanisamy, Kishore
AU  - Maeda, Ichiro
AU  - Takeuchi, Osamu
AU  - Suzuki, Nao
AU  - Yudo, Kazuo
AU  - Bernal, Juan A
AU  - Sato, Ko
PY  - 2024
UR  - https://hdl.handle.net/20.500.12105/26402
AB  - The overexpression of Polo-like kinase 1 (PLK1) is associated with poor clinical outcomes in various malignancies, making it an attractive target for anticancer therapies. Although recent studies suggest PLK1's involvement in homologous recombination...
LA  - eng
PB  - Nature Publishing Group
KW  - Cancer
KW  - Homologous recombination
KW  - Overexpression
KW  - PARP inhibition
KW  - PLK1
TI  - PLK1 overexpression suppresses homologous recombination and confers cellular sensitivity to PARP inhibition.
TY  - research article
ER  -